Clinical trial
Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA…
NCT00148460 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00148460 |
|---|---|
| Title | Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction |
| Official title | A Randomised, Open-label, Multi-center, Angiographic Trial to Compare the Efficacy and Safety of Single Bolus of Tenecteplase (Metalyse®) With Accelerated Infusion of Alteplase in Asian Patients With Acute Myocardial Infarction |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | TNK-tPA, rt-PA |
| Enrollment | 270 |
| Start date | Mar 1, 2001 |
| Completion | Feb 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Oct 29, 2013 |
| Countries | China, Hong Kong, South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: